Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

San Francisco, California 94110


This study's purpose is to learn how dehydroepiandrosterone (DHEA) affects the HIV virus, the immune system, hormone levels, body composition and quality of life.


Inclusion criteria: - Evidence of HIV-1 infection - HIV RNA <50 copies/mL - Stable antiretroviral treatment regimen for at least 8 weeks - Age 18 years or older - Normal pap smear and mammograph within 1 year (females) - Normal prostate-specific antigen level with in one year, age adjusted (males) Exclusion criteria: - Active opportunistic infections or malignancy other than localized cutaneous KS lesions - Concurrent or prior use within the past 8 weeks of DHA, testosterone, other anabolic steroids, corticosteroids, megestrol acetate, growth hormone, IL-2, or thalidomide - Diagnosis of AIDS Dementia Complex (stage II or higher) - Active substance abuse (e.g., alcohol or injection drugs) - Evidence of severe liver dysfunction or hepatic transaminases greater than 3x the upper normal limit - Pregnant or breast-feeding - History of endocrinologically-responsive tumors (e.g., breast, ovarian, uterine, or prostatic cancer, or malignant melanoma)



Primary Contact:


Backup Contact:


Location Contact:

San Francisco, California 94110
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source: ClinicalTrials.gov

Date Processed: March 16, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.